Icelandirect acquires Soma Labs

Icelandirect LLC, a U.S.-based contract manufacturer for human and pet supplement brands, has acquired Soma Labs, a New Jersey-based supplement manufacturer specializing in solid dosage form production. The transaction closed in February 2026, according to a press release.  The acquisition is an investment in capability ‒ expanding what Icelandirect can build, manufacture, and deliver.

‘For years, we have been known as a leader in lipid and softgel supplement sourcing, formulation, manufacturing and packaging,’ said Brandon Miller, CEO of Icelandirect.  ‘The acquisition of Soma Labs will allow us to take a brand from ingredient and formula all the way through to finished, shelf-ready product ‒ in more formats, at greater scale.’